Editors choice by van Niekerk, JP
EDITOR’S CHOICE

January 2010, Vol. 100, No. 1  SAMJ
Helicobacter pylori
The conventional view that no bacterium could live in the 
stomach because of the high concentration of acid there was 
overturned some 25 years ago, when Drs Barry Marshall and 
Robin Warren of Australia first discovered Helicobacter pylori 
in the stomachs of patients with gastritis and stomach ulcers. 
For rewriting what causes gastritis and gastric ulcers they 
received the Nobel Prize for Medicine and Physiology in 2005. 
H. pylori is one of the most frequent chronic bacterial infections, 
affecting more than 50% of the world’s population, and is 
most prevalent in developing countries. It is a major cause 
of duodenal and gastric ulcers, non-ulcer dyspepsia, gastro-
oesophageal reflux disease and adenocarcinoma of the distal 
stomach. Tanih et al.1 and Kimang’a and colleagues2 studied 
aspects of H. pylori among South Africans and Kenyans, 
respectively.
Antibiotic resistance to H. pylori is recognised as a major 
cause of treatment failure. The high prevalence of resistance to 
metronidazole in developing countries has been linked to the 
frequent use of metronidazole derivatives for the treatment of 
protozoal infections and gynaecological problems. Tanih and 
colleagues therefore studied the susceptibility and resistance 
patterns of 200 strains of H. pylori obtained from gastric 
biopsies of patients attending Livingstone Hospital, Port 
Elizabeth.  They found that multidrug resistance was common. 
This finding is of clinical significance and calls for continuous 
surveillance of antibiograms to guide empiric treatment. They 
advocate the inclusion of ciprofloxacin in the treatment of  
H. pylori in their study environment.
The prevalence of H. pylori infection was found to be high 
in patients with dyspepsia (71%) and asymptomatic controls 
(51%). Kimang’a and colleagues investigated the prevalence 
of H. pylori in dyspeptic patients, its relationship with gastric 
pathologies and associated antibiotic profiles, and compared 
two culture media. They found that the media described 
reduced the time required to culture and isolate bacteria and 
perform susceptibility testing.  Despite the high prevalence of 
H. pylori infection, the associated pathology was low and did 
not parallel H. pylori prevalence in the community. 
Trichomoniasis in pregnancy and low 
birth weight or preterm birth
Preterm birth is an important cause of neonatal morbidity and 
mortality worldwide. Studies have suggested that bacterial 
infections of the placenta and fetal membranes may play a 
major role in preterm birth. Some studies have suggested that 
infection with Trichomonas vaginalis may increase the risk of 
preterm birth, and a prevalence of 17 - 42% has been reported 
among adults in eastern and southern Africa. Two studies have 
suggested that treatment of trichomoniasis with metronidozole 
in pregnancy is associated with an increased risk of preterm 
birth and low birth weight. 
Elizabeth Stringer and colleagues performed a randomised 
trial to determine whether treatment of trichomoniasis 
increases the risk of prematurity.3 Their study included  
2 428 women-infant pairs from four sites in Africa of which 
428 (18%) had trichomoniasis at enrolment. They found no 
differences in pregnancy outcomes among women diagnosed 
with trichomoniasis compared with women without 
trichmoniasis. As in other studies, women who received 
antibiotic treatment for trichomoniasis were more likely to 
have resolution of their trichomoniasis. 
They conclude that neither trichomoniasis nor its treatment 
appears to influence the risk of preterm birth in pregnant 
women in sub-Saharan Africa. 
Did Julius Caesar have a brain tumour?
Julius Caesar (100 - 44 BC) was one of the outstanding leaders 
of antiquity.4 Remembered for his military achievements, he 
was also a cultured person, a writer and historian, and an 
outstanding orator and statesman. Through his constitutional 
reforms he paved the way for the founding of the Roman 
Empire. He was tall, well built and fair. To his disappointment, 
he started turning bald early in life, and took to wearing a 
laurel wreath (originally acquired as an emblem of esteem) to 
hide the baldness. Caesar was married three times and had 
many mistresses, including the wives of friends and colleagues. 
In many military campaigns, including the Gallic wars and 
the invasion of Britain, he proved to be an outstanding 
general. His victories ensured widespread popularity but 
growing opposition from his enemies in the Senate. The Senate 
ordered him to resign and to report to Rome. Caesar refused, 
symbolically crossed the Rubicon River, and defeated Pompey 
as the senate’s defender of Rome. 
Returning to Rome Caesar received many honours including 
the post of dictator. On 15 March 44 BC (the Ides of March) he 
was assassinated during a meeting of the Senate. 
Retief and Cilliers suggest that Julius Caesar’s epilepsy, 
which first manifested after he turned 50, was secondary to 
underlying cranial pathology, possibly a benign brain tumour. 
Terminal erratic behaviour may have caused him to be 
negligent about his own safety.
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